Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The study is designed to demonstrate the short term efficacy and safety of vildagliptin 50 mg
bid in patients with Type 2 Diabetes Mellitus inadequately controlled with Metformin.